Dendrogenix is a biopharmaceutical company based in Liège (Belgium) dedicated to developing first in class molecules named "Dendrogenins" addressing important medical needs in the field of neurodegenerative diseases, in particular in Hearing Loss indication, and in the field of Oncology.
View Top Employees from Dendrogenix| Website | http://www.dendrogenix.com |
| Revenue | $2 million |
| Employees | 13 (7 on RocketReach) |
| Founded | 2018 |
| Address | Avenue de l'hôpital 11, Liège, Région Wallonne 4000, BE |
| Industry | Biotechnology, Manufacturing General, Drug Discovery, Manufacturing |
| Competitors | Epicyte Pharmaceutical , Inc., Xsira Pharmaceuticals , Inc. |
| SIC | SIC Code 28 Companies, SIC Code 80 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Dendrogenix employee's phone or email?
Dendrogenix Questions
The Dendrogenix annual revenue was $2 million in 2024.
7 people are employed at Dendrogenix.
Dendrogenix is based in Liège, Région Wallonne.
The NAICS codes for Dendrogenix are [32, 3254, 325].
The SIC codes for Dendrogenix are [28, 80, 283].
Top Dendrogenix Employees
